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1. Introduetion 
Methoxyamine r acts electively with a small per- 
centage of the cytosine bases in mixed E. coli tRNA, 
producing a uniform loss in acceptor activity [ 1 ]. In 
su]i I tyrosine-tRNA the specific ytosines which react 
with methoxyamine have been characterised [2] (fig. 
1). The effect of the individual modifications on ac- 
ceptor activity has now been established by examining 
the chargeable RNA after methoxyamine treatment. 
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÷ Fig. 1. Reactive cytosines inSUli I tyrosine-tRNA. C* signifies 
cytosines reactive with methoxyamine and C + indicates partial 
reactivity. 
This tRNA differs from the non-chargeable solely 
with respect to modification of the 3'-terminal cyto- 
sines. 
2. Materials and methods 
32P-labelled transfer RNA, specifically enriched 
in su~ii, was prepared from E. coli CA274 [3]. Tyro- 
sine-tRNA, with A38 unmodified [4], was isolated 
by fractionation on a BD cellulose column [5]. This 
tRNA was aminoacylated with 3H-tyrosine using 
tyrosyl RNA synthetase purified by ammonium sul- 
phate precipitation and DEAE cellulose chromato- 
graphy [6]. The aminoacylated tRNA was purified 
by phenoxyacetylation, similar to that described by 
Gillam et al. [7], and BD cellulose chromatography 
(fig. 2). The phenoxyacetylated aminoacyl-tRNA was 
hydrolysed by incubation in 2 M tris (pH 9.1) at 37 ° 
for 30 min. 
Methoxyamine treatment was with 3 M reagent 
(pH 5.5), in 10 mM MgClz, for 8 hr at 37 °. The RNA 
was recovered by ethanol precipitation from 0.2 M 
acetate (pH 5.0). Nucleotide sequences were deter- 
mined by the method of Sanger et al. [8]. 
3. Results and discussion 
Fully chargeable tyrosine-tRNA, isolated by the 
procedure of phenoxyacetylation, wasincubated with 
3 M methoxyamine for 8 hr. The modified RNA 
charged with aH-tyrosine to 26 percent of its original 
acceptance. After aminoacylation the RNA was 
phenoxyacetylated an fractionated on a BD cellulose 
column (fig. 3). The three peaks were examined by Tl 
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Fig. 2. Purification of tyrosine-tRNA. Transfer RNA, charged 
with 3H-tyrosine and phenoxyacetylated, was applied to a 
small BD cellulose column and eluted with an acetate buffer 
(10 mM, pH 5.0) containing 10 mM MgC12, 3 mM mercapto- 
ethanol and 1.0 M NaC1 (fractions 1-5); 1.0 M NaCI, 5 per- 
cent EtOH (fractions 6-8) ;  1.0 M NaCI, 10 percent EtOH 
(fractions 9~14). 
ribonuclease digestion followed by two dimensional 
electrophoresis (fig. 4). The two non-chargeable RNA 
peaks presumably reflect a small quantitative differ- 
ence in modification, as they yielded essentially iden- 
tical fingerprints. In contrast, he fingerprint of the 
chargeable RNA differed markedly from the finger- 
prints of the non-chargeable in the relative amounts 
of the modified 3'-terminal sequences. The 3'-end 
with both cytosines modified was a minor component 
(16 percent) of the 3'-terminal sequences in the 
chargeable RNA fraction whereas it was the major 
species (66 percent) in the non-chargeable fraction 
(table 1). The relative amounts of the other modified 
sequences were similar for chargeable and non-charge- 
able RNA. It is concluded that methoxyamine modifi- 
cation of the 3'-terminal cytosines inhibits aminoacyla- 
tion, in contrast to the modification of the other re- 
active cytosines. 
Some aspects of the experimental procedure warrant 
further discussion. In a control experiment with the 
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Fig. 3. F ract ionat ion  o f  chargeable and non-chargeable 
methoxyamine  mod i f ied  tRNA.  Phenoxyacety la ted  RNA was 
chromatographed on  a BD cel lulose co lumn accord ing  to  the 
procedure  of  fig. 1. The  e lut ion  buf fe r  conta ined  1.0 M NaC1 
(fractions 1-4); 1.0 M NaC1, 5 percent EtOH (fractions 5-9); 
1.0 M NaCI, 10 percent EtOH (fractions 10-13,) and 2.0 M 
NaC1, 20 percent EtOH (fractions 14-17). 
:aminoacylation step omitted, 4 percent of the RNA 
eluted in the "chargeable" fraction compared with 
17 percent of chargeable RNA found in fig. 3. This 4 
percent "spil-over" provides apossible xplanation 
for the small fraction of RNA containing the doubly 
modified 3'-end eluting in the "chargeable" fraction. 
Alternatively this RNA may charge at a greatly dimi- 
nished rate, although no acceptor activity was found 
for fractions 1-9 (fig. 3). A second point to be con- 
sidered is loss in acceptor activity which is not due to 
the effect of the reagent. Treatment of mixed tRNA, 
from E. coli CA265, with 3 M methoxyamine for 20 
hr results in 74 percent loss in acceptor activity [1]. 
Under identical reaction conditions, but in the absence 
of the reagent, 9 percent loss in amino acid acceptance 
is observed. This loss in acceptor activity, which is not 
due to the reagent, would be expected to be consider- 
ably greater for the overall experimental procedure. 
Non-chargeable RNA, with one or neither of the 3'- 
terminal cytosines modified could be accounted for 
by this factor. 
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Fig. 4a -c .  T l ribonuclease fingerprints of methoxyamine tyrosine tRNA. Separation is by electrophoresis on cellulose acetate at 
pH 3.5 in 7 M urea (right to left) followed by el¢ctrophoresis on DEAE paper in 7 percent formic acid 3' END refers to the sequence 
AAUCCUUCCCCCACCACCA-OH; 3' END C* refers to the same sequence with one of the two 3'-terminal cytosines modified; 3' 
END 2C* refers tO the same sequence with both of the terminal cytosines modified; ACI refers to the sequence ACUC* UAAAq, 
+ 
CUG and AC2 refers to the sequence AC*UC*UAAAg, CUG. (a) is the T 1 fingerprint of unmodified SUli I tRNA. Fractions 5 -7  
(b), and 15 (c) are from the column described in fig. 3. 
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Table 1 
tiantitation of T 1 ribonuclease. derived oligonueleotides 
from chargeable and nonchargeable, methoxyamine modified, 
tyrosine tRNA. 
Sequence 
Molar yield 
CCAAAG 
CXAAAG 
C*G,G 
UC*AUC*G 
UCAUC*G 
ACUC*UAAA+CUG 
AC*UC*UAAAWUG 
3’ END 
3’ END C* 
3’ END 2C* 
Nonchargeable Chargeable 
0.15 0.07 
0.61 0.64 
0.31 0.36 
0.17 0.16 
0.91 0.87 
0.83 0.67 
0.11 0.13 
0.04 0.14 
0.17 0.43 
0.40 0.11 
Nonchargeable tRNA refers to fractions 5-7 (fii. 3) and 
chageable tRNA refers to fraction 15 (fip. 3). Oligonucleo- 
tides were counted in a scintillation counter and are related 
to TWG on a molar basis. The low yield of the 3’-terminal 
fragment is a characteristic feature of this tRNA. 
Table 2 
AC content of 3’-terminal fragments 
AC (molar yield) 
3’ END C* chargeable 1.47 
3’ END C* non-chargeable 1.50 
3’ END 2C* 0.83 
3’ END 1.75 
Pancreatic ribonuclease digestion products were separated by 
electrophoresis on DEAE paper at pH 3.5. The AC content 
was determined relative to AAU. The abbreviations used are 
explained in fig. 4. 
Fig. 4c. 
That RNA with one 3’-terminal cytosine modified 
can be charged is quite clear from fig. 4 and table 1. 
This RNA may be subdivided according to whether 
the modification is at C83 or C84 and these two clas- 
ses differ in the AC content of their 3’-terminal Ti 
fragments. The Tr fragment modified at C83 contains 
one AC dinucleotide whereas the Tr fragment modi- 
fied at C84 contains two AC dinucleotides. The AC 
content has been estimated after digestion with pan- 
creatic ribonuclease (table 2). In evaluating the data 
in table 2 it should be noted that methoxyamine mo- 
dification at C84 may inhibit the pancreatic cleavage 
of the C83-C84 phosphate bond [2] and thus the 
apparent AC content of the singly modified 3’-termi- 
nal sequences may be anomalously low. From the 
evidence in table 2 it is therefore concluded that 
methoxyamine modification of C84 does not prevent 
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5. Modifications of su~i I tRNA which do not Fig. prevent en- 
zymatic aminoacylation with tyrosine. The modified bases are 
represented by e. It should be noted that the kinetics of amino- 
acylation of the modified tRNAs are not necessarily the same 
for the su~i I tRNA. The modifications are explained in as  
table 3. 
the aminoacylation f tyrosine-tRNA. The evidence 
does not allow a decision regarding the effect of mo- 
dification of C83. 
Methoxyamine modification of both 3'-terminal 
cytosines of su]I tyrosine-tRNA inhibits aminoacyla- 
tion, in contrast to the modification of the other re- 
active cytosines. For the experimental conditions des- 
cribed in this report, modification of both 3'-terminal 
cytosines accounts for approximately 70 percent of 
the non-chargeable species. Similar results regarding 
the inactivation of formylmethionine-tRNA by ultra- 
violet light induced modification of the 3'-terminal 
cytosines have recently been reported by Schulman 
[9]. The universal nature of these terminal cytosines 
precludes their involvement in a specific binding re- 
action with the synthetase and the inhibitory effect of 
modification ismore likely to involve the catalytic 
stage in acylation. 
The nucleotides C-16, 19, 33, 35,48 and 51 can 
Table 3 
Modifications of SU~l I tRNA which do not prevent enzymatic 
aminoacylation with tyrosine. 
4" SUll I nucleoUde Modified nucleotide Ref. 
G2 A 5 
Cl l  U (U11A25) 5 
G15 A 3 
C16 C* 
C16 U (U16U31) 10 
Gml7 A 3, 11 
Gml7 G 12 
C19 C* 
G25 A (U11A25) 5 
G31 A 3 
G31 U 10, 13 
C33 C* 
C35 C* 
C35 G* 3 
A'38 A 4 
C41 U (A31U41) 13 
G46 A 13 
C48 C* 
C51 C* 
C54 U (A46U51) 13 
C80 U (A2U80) 5 
C81 A 5 
C84 C* 
The following abbreviations are used: C*, methoxyamine mo- 
dified cytosine; G*, a modified G aad A*, 2-methylthio-N- 
(6)-isopentenyl-A. Where a double mutant isspecified this 
means that the single mutant has not been examined for tyro- 
sine acceptance, unless given elsewhere inthe table. 
now be added to a rather extensive list of nucleotides 
which can be modified either chemically, mutagenical- 
ly or in vivo without preventing the enzymatic amino- 
acylation with tyrosine of su m tRNA (fig. 5 and table 
3). 
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